Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cheung

Showing results (281-290 of 289) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 289 results.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Journal of Translational Medicine|October 11, 2012
Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trialWei He, Dongmin Wang, Zhangqun Ye, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Pageof 29

Showing results (281-290 of 289) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 289 results.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Journal of Translational Medicine|October 11, 2012
Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trialWei He, Dongmin Wang, Zhangqun Ye, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Pageof 29